Osteoporosis International

, Volume 20, Issue 11, pp 1881–1887 | Cite as

Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D

  • C. B. Franco
  • G. Paz-Filho
  • P. E. Gomes
  • V. B. Nascimento
  • C. A. M. Kulak
  • C. L. Boguszewski
  • V. Z. C. BorbaEmail author
Original Article



We did a cross-sectional analysis of chronic pulmonary obstructive disease (COPD) patients without chronic use of systemic glucocorticoids (CUG). Osteoporosis was found in 51% and bone mineral density (BMD) was correlated with severity of disease. Low levels of vitamin D were found in 94%. All COPD patients may benefit from vitamin D supplementation and screening for low BMD.


Patients with chronic pulmonary obstructive disease have low bone mineral density, caused by chronic use of systemic glucocorticoids and hypovitaminosis D. However, patients without CUG may also have low BMD.


We performed a cross-sectional analysis in 49 patients (21 men, 28 postmenopausal women), with COPD without CUG, from Brazil (25° 25' S). Several markers of bone metabolism were measured, plus BMD. Osteoporosis risk factors and history of fractures were investigated. Respiratory function was assessed by venous gasometry, spirometry, and oximetry. BMD results were compared to those of 40 healthy non-smokers controls.


COPD patients had lower BMD at all sites (p < 0.01). Osteoporosis was observed in 51%. BMD independently correlated with stage of disease (lumbar spine, R = 0.38, p = 0.01; total femur, R = 0.36, p = 0.01; femoral neck, R = 0.40, p < 0.01). Ninety-four percent had low levels of vitamin D (<30 ng/mL) and 67% had secondary hyperparathyroidism. Vitamin D was correlated with oxygen saturation (R = 0.36, p = 0.01), with lower levels in those with saturation <88% (p = 0.01).


Patients with COPD without CUG have increased risk for osteoporosis. Such patients have hypovitaminosis D, which is correlated with the severity of disease. Screening for low BMD and vitamin D supplementation may be warranted to all COPD patients.


BMD Bone COPD Glucocorticoids Osteoporosis Vitamin D 



We thank Dr. Lêda Maria Rabelo for her assistance during the preparation of this manuscript.

Conflicts of interest



  1. 1.
    Biskobing DM (2002) COPD and osteoporosis. Chest 121(2):609–620CrossRefPubMedGoogle Scholar
  2. 2.
    Iqbal F, Michaelson J, Thaler L et al (1999) Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest 116(6):1616–1624CrossRefPubMedGoogle Scholar
  3. 3.
    Jorgensen NR, Schwarz P (2008) Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 14(2):122–127CrossRefPubMedGoogle Scholar
  4. 4.
    Kanis JA, Johansson H, Oden A et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19(6):893–899CrossRefPubMedGoogle Scholar
  5. 5.
    McEvoy CE, Ensrud KE, Bender E et al (1998) Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(3 Pt 1):704–709PubMedGoogle Scholar
  6. 6.
    Vrieze A, de Greef MH, Wijkstra PJ, Wempe JB (2007) Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int 18(9):1197–1202CrossRefPubMedGoogle Scholar
  7. 7.
    Incalzi RA, Caradonna P, Ranieri P et al (2000) Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med 94(11):1079–1084CrossRefPubMedGoogle Scholar
  8. 8.
    Papaioannou A, Parkinson W, Ferko N et al (2003) Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int 14(11):913–917CrossRefPubMedGoogle Scholar
  9. 9.
    Karadag F, Cildag O, Yurekli Y, Gurgey O (2003) Should COPD patients be routinely evaluated for bone mineral density? J Bone Miner Metab 21(4):242–246PubMedGoogle Scholar
  10. 10.
    Fabbri LM, Hurd SS (2003) Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 22(1):1–2CrossRefPubMedGoogle Scholar
  11. 11.
    Dubois EF, Roder E, Dekhuijzen PN et al (2002) Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens. Chest 121(5):1456–1463CrossRefPubMedGoogle Scholar
  12. 12.
    NCAAA. Task Force on Recommended Alcohol Questions—National Council on Alcohol Abuse and Alcoholism Recommended Sets of Alcohol Consumption Questions 2003 [cited 2008 September 15]; Available from:Google Scholar
  13. 13.
    Lolio C, Souza J, Santo A, Buchalla C (1993) Prevalence of smoking in a city of southeastern Brazil. Rev Saúde Pública 27:4Google Scholar
  14. 14.
    Lloyd T, Rollings N, Eggli DF et al (1997) Dietary caffeine intake and bone status of postmenopausal women. Am J Clin Nutr 65(6):1826–1830PubMedGoogle Scholar
  15. 15.
    Expert Panel Report 3 (EPR-3) (2007) Guidelines for the diagnosis and management of asthma—summary report 2007. J Allergy Clin Immunol 120(5 Suppl):S94–S138Google Scholar
  16. 16.
    Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281CrossRefPubMedGoogle Scholar
  17. 17.
    Hans D, Downs RW Jr, Duboeuf F et al (2006) Skeletal sites for osteoporosis diagnosis: the 2005 ISCD Official Positions. J Clin Densitom 9(1):15–21CrossRefPubMedGoogle Scholar
  18. 18.
    Knudson RJ, Slatin RC, Lebowitz MD, Burrows B (1976) The maximal expiratory flow-volume curves normal standards variability and effect of age. Am Rev Respir Dis 113:587–600PubMedGoogle Scholar
  19. 19.
    Standardization of Spirometry (1995) 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 152(3):1107–1136Google Scholar
  20. 20.
    Jorgensen NR, Schwarz P, Holme I et al (2007) The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 101(1):177–185CrossRefPubMedGoogle Scholar
  21. 21.
    Katsura H, Kida K (2002) A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest 122(6):1949–1955CrossRefPubMedGoogle Scholar
  22. 22.
    Forli L, Halse J, Haug E et al (2004) Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J Intern Med 256(1):56–62CrossRefPubMedGoogle Scholar
  23. 23.
    Kjensli A, Mowinckel P, Ryg MS, Falch JA (2007) Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone 40(2):493–497CrossRefPubMedGoogle Scholar
  24. 24.
    Lekamwasam S, Trivedi DP, Khaw KT (2002) An association between respiratory function and bone mineral density in women from the general community: a cross sectional study. Osteoporos Int 13(9):710–715CrossRefPubMedGoogle Scholar
  25. 25.
    Lekamwasam S, Trivedi DP, Khaw KT (2005) An association between respiratory function and hip bone mineral density in older men: a cross-sectional study. Osteoporos Int 16(2):204–207CrossRefPubMedGoogle Scholar
  26. 26.
    Sin DD, Man JP, Man SF (2003) The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med 114(1):10–14CrossRefPubMedGoogle Scholar
  27. 27.
    Riancho JA, Gonzalez Macias J, Del Arco C et al (1987) Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease. Thorax 42(12):962–966CrossRefPubMedGoogle Scholar
  28. 28.
    Goldstein MF, Fallon JJ Jr, Harning R (1999) Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest 116(6):1733–1749CrossRefPubMedGoogle Scholar
  29. 29.
    de Vries F, van Staa TP, Bracke MS et al (2005) Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 25(5):879–884CrossRefPubMedGoogle Scholar
  30. 30.
    Elmstahl S, Ekstrom H, Johnell O et al (2006) No association between inhaled corticosteroids and whole body DXA in postmenopausal women. Pharmacoepidemiol Drug Saf 15(7):527–535CrossRefPubMedGoogle Scholar
  31. 31.
    Halpern MT, Schmier JK, Van Kerkhove MD et al (2004) Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis. Ann Allergy Asthma Immunol 92(2):201–207 quiz 7-8, 67PubMedCrossRefGoogle Scholar
  32. 32.
    Jones AM, Munavvar M, Vail A et al (2002) Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisolone in acute adult asthma. Respir Med 96(11):950–954CrossRefPubMedGoogle Scholar
  33. 33.
    Richy F, Bousquet J, Ehrlich GE et al (2003) Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporos Int 14(3):179–190PubMedGoogle Scholar
  34. 34.
    Bandeira F, Griz L, Dreyer P et al (2006) Vitamin D deficiency: a global perspective. Arq Bras Endocrinol Metabol 50(4):640–646PubMedGoogle Scholar
  35. 35.
    Saraiva GL, Cendoroglo MS, Ramos LR et al (2005) Influence of ultraviolet radiation on the production of 25 hydroxyvitamin D in the elderly population in the city of Sao Paulo (23 degrees 34'S), Brazil. Osteoporos Int 16(12):1649–1654CrossRefPubMedGoogle Scholar
  36. 36.
    Dimai HP, Domej W, Leb G, Lau KH (2001) Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia. J Bone Miner Res 16(11):2132–2141CrossRefPubMedGoogle Scholar
  37. 37.
    Donovan DS Jr, Papadopoulos A, Staron RB et al (1998) Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 157(6 Pt 1):1892–1899PubMedGoogle Scholar
  38. 38.
    Sutherland ER, Cherniack RM (2004) Management of chronic obstructive pulmonary disease. N Engl J Med 350(26):2689–2697CrossRefPubMedGoogle Scholar
  39. 39.
    Black PN, Scragg R (2005) Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 128(6):3792–3798CrossRefPubMedGoogle Scholar
  40. 40.
    Melamed ML, Michos ED, Post W, Astor B (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168(15):1629–1637CrossRefPubMedGoogle Scholar
  41. 41.
    Thomas MK, Lloyd-Jones DM, Thadhani RI et al (1998) Hypovitaminosis D in medical inpatients. N Engl J Med 338(12):777–783CrossRefPubMedGoogle Scholar
  42. 42.
    Gerdhem P, Obrant KJ (2002) Effects of cigarette-smoking on bone mass as assessed by dual-energy X-ray absorptiometry and ultrasound. Osteoporos Int 13(12):932–936CrossRefPubMedGoogle Scholar
  43. 43.
    Law MR, Hackshaw AK (1997) A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 315(7112):841–846PubMedGoogle Scholar
  44. 44.
    Szulc P, Garnero P, Claustrat B et al (2002) Increased bone resorption in moderate smokers with low body weight: the Minos study. J Clin Endocrinol Metab 87(2):666–674CrossRefPubMedGoogle Scholar
  45. 45.
    Ward KD, Klesges RC (2001) A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 68(5):259–270CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2009

Authors and Affiliations

  • C. B. Franco
    • 1
  • G. Paz-Filho
    • 1
  • P. E. Gomes
    • 1
  • V. B. Nascimento
    • 1
  • C. A. M. Kulak
    • 1
  • C. L. Boguszewski
    • 1
  • V. Z. C. Borba
    • 1
    Email author
  1. 1.Serviço de Endocrinologia e Metabologia do Hospital de Clínicas da Universidade Federal do Paraná (SEMPR)CuritibaBrazil

Personalised recommendations